(4R)-4-Isopropyl-1-methyl-7-oxabicyclo[4.1.0]heptane, 95.0%, 100g

3,4-Dimethoxyphenylacetic acid hydrazide, 95.0%, 25g

1-(3,5-di-tert-butylphenyl)methanamine hydrochloride, 100mg

N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 25g

4-(2,4-Dichlorophenyl)-3-thiosemicarbazide, 1g

(S)-Ethyl 2-(3-amino-2-oxopiperidin-1-yl)acetate hydrochloride, 95.0%, 100mg

(6R,7R)-7-Amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 10g

5-Methyl-1-phenyl-1H-[1,2,3]triazole-4-carboxylic acid, 95.0%, 250mg

2,6-Dichloro-3-hydroxyisonicotinic acid, 95.0%, 1g

m-Tolylhydrazine, 95.0%, 5g

tert-Butyl (3-bromo-4-methylphenyl)carbamate, 95.0%, 5g

Microliter syringe MICROLITER® series 7000 Point type 2, 0.5 µl, 7000.5 KH, 1 Piece

Sucralose>98.0%(HPLC)5g